Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1973 2
1975 1
1977 1
1979 3
1980 3
1982 1
1983 3
1984 2
1985 3
1986 1
1987 2
1988 3
1989 3
1990 4
1991 7
1992 4
1993 5
1994 7
1995 5
1996 4
1997 3
1998 5
1999 2
2001 5
2002 4
2003 3
2004 3
2005 7
2006 6
2007 14
2008 19
2009 8
2010 6
2011 13
2012 9
2013 2
2014 4
2015 4
2016 5
2017 2
2018 4
2019 2
2020 1
2021 1
2022 2
2023 3
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193 results

Results by year

Filters applied: . Clear all
Page 1
Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study.
Candido R, Nicolucci A, Larosa M, Rossi MC, Napoli R; RESTORE-G (Retrospective analysis on the therapeutic approaches after GLP-1 RA treatment in type 2 diabetes patients) Study Group. Candido R, et al. Nutr Metab Cardiovasc Dis. 2024 Aug;34(8):1846-1853. doi: 10.1016/j.numecd.2024.03.023. Epub 2024 Mar 23. Nutr Metab Cardiovasc Dis. 2024. PMID: 38693036 Free article.
Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study.
Candido R, Nicolucci A, Larosa M, Rossi MC, Napoli R; RESTORE-G (Retrospective analysis on the therapeutic approaches after GLP-1 RA treatment in type 2 diabetes patients) Study Group. Candido R, et al. Nutr Metab Cardiovasc Dis. 2023 Nov;33(11):2294-2305. doi: 10.1016/j.numecd.2023.07.025. Epub 2023 Jul 22. Nutr Metab Cardiovasc Dis. 2023. PMID: 37679243 Free article.
Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED.
Scaramuzza A, Cherubini V, Tumini S, Bonfanti R, Buono P, Cardella F, d'Annunzio G, Frongia AP, Lombardo F, Monciotti AC, Rabbone I, Schiaffini R, Toni S, Zucchini S, Frontino G, Iafusco D; Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetology. Scaramuzza A, et al. Acta Diabetol. 2014 Apr;51(2):173-84. doi: 10.1007/s00592-013-0521-7. Epub 2013 Oct 27. Acta Diabetol. 2014. PMID: 24162715 Review.
Cox and mesothelioma: an overview.
Cardillo I, Spugnini EP, Verdina A, Galati R, Citro G, Baldi A. Cardillo I, et al. Among authors: citro g. Histol Histopathol. 2005 Oct;20(4):1267-74. doi: 10.14670/HH-20.1267. Histol Histopathol. 2005. PMID: 16136507 Review.
Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids.
Spitalieri P, Centofanti F, Murdocca M, Scioli MG, Latini A, Di Cesare S, Citro G, Rossi A, Orlandi A, Miersch S, Sidhu SS, Pandolfi PP, Botta A, Sangiuolo F, Novelli G. Spitalieri P, et al. Among authors: citro g. Cells. 2022 Apr 5;11(7):1235. doi: 10.3390/cells11071235. Cells. 2022. PMID: 35406799 Free PMC article.
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study.
Napoli R, Nicolucci A, Larosa M, Rossi MC, Candido R; RESTORE‐G (Retrospective analysis on the therapeutic approaches after GLP‐1 RA treatment in type 2 diabetes patients) Study Group. Napoli R, et al. Diabetes Obes Metab. 2024 Sep;26(9):3576-3586. doi: 10.1111/dom.15697. Epub 2024 Jun 10. Diabetes Obes Metab. 2024. PMID: 38853712
Cell-cycle molecules in mesothelioma: an overview.
Spugnini EP, Campioni M, D'Avino A, Caruso G, Citro G, Baldi A. Spugnini EP, et al. Among authors: citro g. J Exp Clin Cancer Res. 2007 Dec;26(4):443-9. J Exp Clin Cancer Res. 2007. PMID: 18365537 Review.
193 results